The study also revealed the possible heterogeneity of TNNI3 mutations across ethnic and geographic backgrounds, suggesting that long-term studies of genetic mutations should be strengthened in the future to promote the development of precision treatment strategies for cardiomyopathy. The gene discussed is TNNI3; the disease is cardiomyopathy.